In Focus: studying the COVID-19 pandemic – a Special Focus Issue
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
Browsing: Respiratory Infection
Stuck in the past – testing polymicrobial lung infections in cystic fibrosis
By investigating the lung microbiome we can increase our understanding and therefore treatment avenues for CF lung infections.
Cytokine storm could sabotage long-term immunity against SARS-CoV-2
COVID-19 patients who develop a cytokine storm in response to infection could be unable to produce memory cells that provide long-term protection against SARS-CoV-2.
Asymptomatic COVID-19 patients still carry the same amount of virus
A study undertaken in South Korea has shown that the viral load in asymptomatic COVID-19 patients is the same as in those who show symptoms of the disease and this could be contributing to the spread of the infection in populations.
Fungal biofilm morphology impacts disease progression
Researchers at Dartmouth’s Geisel School of Medicine have found that hypoxic conditions are linked to a hypoxia-typic morphotype of the pathogen Aspergillus fumigatus. This morphotype worsens the diseases progression of invasive aspergillosis in a murine model.
Streptococcus pneumoniae use bleaching agent to help cause infection
New research shows that hydrogen peroxide released by Streptococcus pneumoniae inhibits key components of the innate immune system. This contributes to the successful pathogen colonization of the host and causes pneumonia.
Does dietary zinc intake increase protection against Streptococcus pneumoniae?
New research has discovered a link between dietary zinc intake and protection against Streptococcus pneumoniae, suggesting it aids the immune system.
ECCMID19: Infant’s gut microbiota could impact early respiratory health
Mode of delivery can alter an infant’s gut microbiota, irrespective of maternal antibiotic exposure, and this in turn could impact respiratory health in the first year of life, according to research presented at ECCMID.
Infographic: The pipeline for RSV vaccines
In this infographic we take a look at the RSV vaccines currently in the clinical pipeline and their target population from Phase I to Phase III.
A peek behind the paper – Hessel van der Weide on antibiotic-nanomedicines
Take a look behind the scenes of a recent Future Microbiology paper as we ask the authors about the challenges in treating respiratory tract infections and how nanomedicines could help.
